Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citasoxacin vs levofloxacin for acute respiratory or urinary tract infection
CTR20150162Phase 3Active
- Sponsor
- Roxin Pharmaceutical
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of citasoxacin in Acute bacterial lower respiratory tract infection (ABLRTI), upper respiratory infection (URI), Acute Urinary Tract Infection (UTI), sponsored by Roxin Pharmaceutical. Started Sep 2015; status: active.
02
Drugs
citasoxacin
03
Conditions
Acute bacterial lower respiratory tract infection (ABLRTI)upper respiratory infection (URI)Acute Urinary Tract Infection (UTI)
Beyond the preview
Go deeper on CTR20150162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150162.